No black box warning on record for Leucovorin Calcium

As of the latest FDA labeling reviewed, Leucovorin Calcium (LEUCOVORIN CALCIUM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Leucovorin Calcium medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS In the treatment of accidental overdosages of folic acid antagonists, intravenous leucovorin should be administered as promptly as possible. As the time interval between antifolate administration (e.g., methotrexate) and leucovorin rescue increases, leucovorin's effectiveness in counteracting toxicity decreases. In the treatment of accidental overdosages of intrathecally adminstered folic

No black box warning on record for Leucovorin Calcium

Other warnings & precautions

WARNINGS In the treatment of accidental overdosages of folic acid antagonists, intravenous leucovorin should be administered as promptly as possible. As the time interval between antifolate administration (e.g., methotrexate) and leucovorin rescue increases, leucovorin's effectiveness in counteracting toxicity decreases. In the treatment of accidental overdosages of intrathecally adminstered folic

Leucovorin Calcium Black Box Warning

No black box warning on record for Leucovorin Calcium

Other warnings & precautions

Leucovorin Calcium Black Box Warning

No black box warning on record for Leucovorin Calcium

Other warnings & precautions